BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 36987461)

  • 1. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H; Zhu Y; Shen G; Wang Z; Li W
    Clin Interv Aging; 2023; 18():453-465. PubMed ID: 36987461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Risk Nomogram Model for Predicting Contrast-Induced Acute Kidney Injury in Patients with Non-ST-Elevation Acute Coronary Syndrome Undergoing Primary Percutaneous Coronary Intervention.
    Ma K; Li J; Shen G; Zheng D; Xuan Y; Lu Y; Li W
    Clin Interv Aging; 2022; 17():65-77. PubMed ID: 35115770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of systemic immune-inflammation index combined with N-terminal pro-brain natriuretic peptide for contrast-induced acute kidney injury in patients with STEMI after primary PCI.
    Shen G; He H; Zhang X; Wang L; Wang Z; Li F; Lu Y; Li W
    Int Urol Nephrol; 2024 Mar; 56(3):1147-1156. PubMed ID: 37658947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score.
    Araujo GN; Pivatto Junior F; Fuhr B; Cassol EP; Machado GP; Valle FH; Bergoli LC; Wainstein RV; Polanczyk CA; Wainstein MV
    Cardiovasc Interv Ther; 2018 Jul; 33(3):224-231. PubMed ID: 28540634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.
    Gao N; Qi X; Dang Y; Li Y; Wang G; Liu X; Zhu N; Fu J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):513. PubMed ID: 33297955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
    Chatterjee S; Kundu A; Mukherjee D; Sardar P; Mehran R; Bashir R; Giri J; Abbott JD
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):205-212. PubMed ID: 28112470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of small and dense low-density lipoprotein (sd-LDL)on contrast-induced acute kidney injury in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Li Y; Ma K; Shen G; Zheng D; Xuan Y; Li W
    Int Urol Nephrol; 2021 Dec; 53(12):2611-2617. PubMed ID: 33675477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
    Zahler D; Rozenfeld KL; Merdler I; Peri Y; Shacham Y
    Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The investigation of TIMI risk index for prediction of contrast-induced acute kidney injury in patients with ST elevation myocardial infarction.
    Çınar T; Karabağ Y; Ozan Tanık V; Çağdaş M; Rencüzoğulları İ; Öz A
    Acta Cardiol; 2020 Feb; 75(1):77-84. PubMed ID: 30678606
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
    Ye Z; Xu Y; Tang L; Wu M; Wu B; Zhu T; Wang J
    Cardiovasc Diabetol; 2023 Apr; 22(1):87. PubMed ID: 37055777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Nutritional Index Combined with Triglyceride-Glucose Index to Contrast a Nomogram for Predicting Contrast-Induced Kidney Injury in Type 2 Diabetes Mellitus Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention.
    Zhu Y; He H; Qiu H; Zhang X; Wang L; Li W
    Clin Interv Aging; 2023; 18():1663-1673. PubMed ID: 37810953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a predictive model for adverse left ventricular remodeling in NSTEMI patients after primary percutaneous coronary intervention.
    Wang L; Liu T; Wang C; Xuan H; Xu X; Yin J; Li X; Chen J; Li D; Xu T
    BMC Cardiovasc Disord; 2022 Aug; 22(1):386. PubMed ID: 36030211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention.
    Wang Z; Peng J
    Sci Rep; 2023 Mar; 13(1):5084. PubMed ID: 36977721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center.
    Wolff G; Lin Y; Quade J; Bader S; Kosejian L; Brockmeyer M; Karathanos A; Parco C; Krieger T; Heinen Y; Perings S; Albert A; Icks A; Kelm M; Schulze V
    Clin Res Cardiol; 2020 Feb; 109(2):235-245. PubMed ID: 31236693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
    Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
    Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional value of the red blood cell distribution width to the Mehran risk score for predicting contrast-induced acute kidney injury in patients with ST-elevation acute myocardial infarction.
    Mizuno A; Ohde S; Nishizaki Y; Komatsu Y; Niwa K
    J Cardiol; 2015 Jul; 66(1):41-5. PubMed ID: 25448729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.